Who owns AZIYO BIOLOGICS INC?
- Ticker: ELUT
- CUSIP Number: 05479k106
Tip: Access positions for across all investors
Analyze quarterly positions in Aziyo Biologics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aziyo Biologics stock
Who bought or sold AZIYO BIOLOGICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AIGH Capital Management | 3.6M | $3.8M | 17% | Mar 2026 |
|
| Nantahala Capital Management | 3.2M | $3.3M | 0% | Mar 2026 |
|
| Silverarc Capital Management | 2.8M | $1.9M | -3% | Dec 2025 |
|
| Knollwood Investment Advisory | 2.6M | $2.7M | 0% | Mar 2026 |
|
| Vanguard Group | 1.2M | $802k | -2% | Dec 2025 |
|
| Vanguard Capital Management | 1.0M | $1.1M | 100% | Mar 2026 |
|
| Perkins Capital Management | 757k | $795k | -3% | Mar 2026 |
|
| Geode Capital Management | 293k | $308k | 15% | Mar 2026 |
|
| CI Private Wealth | 249k | $262k | 100% | Mar 2026 |
|
| Birchview Capital | 165k | $173k | -37% | Mar 2026 |
|
| BlackRock | 122k | $128k | 19% | Mar 2026 |
|
| Rossmore Private Capital | 120k | $126k | 140% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 119k | $125k | 100% | Mar 2026 |
|
| Citadel Advisors | 112k | $118k | -27% | Mar 2026 |
|
| XTX Topco | 103k | $71k | 100% | Dec 2025 |
|
| Renaissance Technologies | 102k | $71k | 65% | Dec 2025 |
|
| Jane Street | 64k | $67k | 36% | Mar 2026 |
|
| FNY Investment Advisers | 45k | $46k | 21% | Mar 2026 |
|
| Arcus Capital Partners | 30k | $32k | 0% | Mar 2026 |
|
| Northern Trust | 28k | $19k | 0% | Dec 2025 |
|
| Qube Research & Technologies | 20k | $14k | 0% | Dec 2025 |
|
| Brown Advisory Holdings Incorporated | 20k | $21k | 100% | Mar 2026 |
|
| Verdence Capital Advisors | 19k | $20k | 0% | Mar 2026 |
|
| Hardesty Capital Management Corp. | 15k | $15k | 0% | Mar 2026 |
|
| Indie Asset Partners | 13k | $13k | 0% | Mar 2026 |
|
| Fund Evaluation Group | 13k | $13k | 100% | Mar 2026 |
|
| State Street Corporation | 12k | $8.3k | 0% | Dec 2025 |
|
| Family Management Corporation | 10k | $11k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 8.1k | $8.5k | 100% | Mar 2026 |
|
| UBS Group | 7.5k | $7.9k | 25717% | Mar 2026 |
|
| Morgan Stanley | 7.0k | $7.3k | -13% | Mar 2026 |
|
| Tower Research Capital | 6.2k | $4.3k | 19% | Dec 2025 |
|
| Wells Fargo & Company | 5.0k | $5.3k | 212% | Mar 2026 |
|
| Royal Bank of Canada | 242.00 | $0 | 100% | Mar 2026 |
|
| SBI Securities | 55.00 | $57.997500 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 3.00 | $3.000000 | -57% | Mar 2026 |
|
Who sold out of Aziyo Biologics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alyeska Investment Group | Dec 2025 | 1.3M | $888k |
| Virtu Financial | Sep 2025 | 30k | $26k |
| Hrt Financial | Dec 2025 | 23k | $16k |
| Millennium Management | Dec 2025 | 13k | $8.9k |
| Barclays | Sep 2025 | 100.00 | $89.000000 |